Organism: Plasmodium falciparum  
DevelopmentalStage: erythrocytic stages  
AssayName: comparative phosphoproteomics  
ReductionReagent: DTT  
AlkylationReagent: iodoacetamide  
Compound: Shld-1  
Compound: WR99210  
Compound: IBMX  
Compound: BAPTA-AM  
Compound: 8Br-cAMP  
Compound: PKI  
Compound: Neuraminidase  
Compound: chymotrypsin  
ConcentrationOfCompound: 0.25 μM Shld-1  
ConcentrationOfCompound: 2.5 nM WR99210  
ConcentrationOfCompound: 10 nM WR99210  
ConcentrationOfCompound: 250 μM IBMX  
ConcentrationOfCompound: 40 μM BAPTA-AM  
ConcentrationOfCompound: 100 µM 8Br-cAMP  
ConcentrationOfCompound: 20 μM PKI  
ConcentrationOfCompound: 66 mU ml−1 Neuraminidase  
ConcentrationOfCompound: 1 mg ml−1 chymotrypsin  
SourceName: O+ erythrocytes  
Strain: D10  
Strain: 3D7 (MR4)  
Temperature: 37 °C  
Instrument: Orbitrap Fusion Tribrid mass spectrometer  
Instrument: Proxeon Easy-nLC 1000 system  
Separation: reverse-phase liquid chromatography  
GradientTime: 60 min  
GradientTime: 120 min  
FractionationMethod: bRPLC  
EnrichmentMethod: TiO2 based enrichment  
CleavageAgent: Trypsin  
Label: iTRAQ  
AssayName: LC-MS/MS  
PrecursorMassTolerance: 20 ppm  
FragmentMassTolerance: 0.1 Da  
CollisionEnergy: 35% normalized collision energy